Long-term visual outcomes for a treat-&-extend anti-vascular endothelial growth factor regimen in eyes with neovascular age-related macular degeneration: Up to eight-year follow-up

被引:0
|
作者
Javidi, Simon [1 ]
Dirani, Ali [1 ,2 ]
Antaki, Fares [1 ]
Saab, Marc [1 ]
Cordahi, Ghassan [1 ]
机构
[1] Univ Montreal, Ophthalmol, Montreal, PQ, Canada
[2] Univ Laval, Ophthalmol, Quebec City, PQ, Canada
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1200
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Upasani, Deepa
    Dhingra, Narendra
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (09) : 2350 - 2354
  • [42] Three-year outcomes of a treat and extend regimen of aflibercept for neovascular age-related macular degeneration
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Shiode, Yusuke
    Hirano, Masayuki
    Doi, Shinichiro
    Toshima, Shinji
    Takahashi, Kosuke
    Fujiwara, Atsushi
    Kanzaki, Yuki
    Hosogi, Mika
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [43] Implications of discontinuing anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration
    Chang, Andrew A.
    Spooner, Kimberly
    Fraser-Bell, Samantha
    Hong, Thomas
    Wong, James G.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 956 - 956
  • [44] Disparities in access to anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Finger, Robert P.
    Xie, Jing
    Fotis, Kathy
    Parikh, Sumit
    Cummins, Rob
    Mitchell, Paul
    Guymer, Robyn H.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (02): : 143 - 151
  • [45] Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration
    Vedula, S. S.
    Krzystolik, M. G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [46] Retinal pigment epithelial characteristics in eyes with neovascular age-related macular degeneration Long-term retinal changes under anti-vascular endothelial growth factor treatment
    Ebner, Christian
    Wernigg, Clara
    Schuetze, Christopher
    Weingessel, Birgit
    Vecsei-Marlovits, Pia-Veronika
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (3-4) : 123 - 130
  • [47] EPIRETINAL MEMBRANES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Effect on Outcomes of Anti-vascular Endothelial Growth Factor Therapy
    Karaca, Emine Esra
    Yildiz, Burcin Kepez
    Cubuk, Mehmet Ozgur
    Ozdek, Sengul
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (08): : 1540 - 1546
  • [48] Value of Anti-Vascular Endothelial Growth Factor Gene Therapy for Neovascular Age-Related Macular Degeneration
    Berkowitz, Sean T.
    Patel, Shriji
    OPHTHALMOLOGY RETINA, 2021, 5 (04): : 357 - 364
  • [49] Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
    Baris, Mine Esen
    Mentes, Jale
    Afrashi, Filiz
    Nalcaci, Serhad
    Akkin, Cezmi
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2020, 50 (05): : 275 - 282
  • [50] Subfoveal Choroidal Thickness in Eyes with Neovascular Age-Related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents
    Moreira Kanadani, Tereza Cristina
    Veloso, Carlos Eduardo
    Nehemy, Marcio B.
    OPHTHALMOLOGICA, 2018, 240 (04) : 200 - 207